You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
PlusOne: Prototyping and Validation of a Wireless In-Home Breathing Monitor for Prevention of Overdose Deaths
SBC: Xandem Technology LLC Topic: NIDADESCRIPTION provided by applicant This proposal investigates the use of a novel passive personal monitoring system to stem the tide in the epidemic of deaths due to unintentional opioid drug overdoses In the U S in opioid drug overdoses including prescription pain relievers and heroin caused deaths a number that has increased dramatically over the past two decades A person w ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Clinical Text Automatic De-Identification to Support Large Scale Data Reuse and Sharing
SBC: Clinacuity, Inc Topic: 400DESCRIPTION provided by applicant The adoption of Electronic Health Record EHR systems is growing at a fast pace in the U S and this growth results in very large quantities of patient clinical data becoming available in electronic format with tremendous potentials but also equally growing concern for patient confidentiality breaches Secondary use of clinical data is essential to fulfill ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Natural product inspired antibacterials with unique ribosomal binding
SBC: Curza Inc Topic: NIAIDProject Summary The long term objective of this project is to develop a new class of broad spectrum antibiotics focused on Gram negative bacteria Inspired by a natural product this class targets an unexploited binding site of the bacterial ribosome With ever increasing reports of resistance to frontline therapies addressing Gram negatives there is a critical need for new therapies yet very ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
New therapeutics targeting skeletal excessive Fe for thalassemia major bone loss
SBC: NANOMEDIC INC Topic: NICHDDESCRIPTION provided by applicant This is a SBIR Phase I application to develop new iron chelating drugs for prevention and treatment of iron overload induced bone loss in patients with thalassemia major TM a rare disease in the US Virtually all TM patients are affected by osteopenia and osteoporosis and these skeletal complications herald and contribute to a general clinical deterioratio ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
New Peptide Reagent for Imaging Denatured Collagen in Histopathology
SBC: 3HELIX INC Topic: 200DESCRIPTION provided by applicant Helix Inc proposes to develop a new peptide based tissue staining agent for detecting denatured collagen in histopatholgical studies in this Phase I SBIR The founders of Helix Inc Drs Yang Li and Michael Yu discovered a synthetic Collagen Hybridizing Peptide CHP which can specifically bind to the denatured collagen molecules with high affinity the ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Improving vaccine development through high throughput immunogenicity screening
SBC: Carterra, Inc. Topic: NIAIDAbstract Vaccines are fundamental in preventing debilitating illnesses and saving millions of lives each year But despite these vaccine oriented victories infectious diseases are still the second leading cause of death as well as the leading cause of disability adjusted life years worldwide About six million deaths were attributed to AIDS malaria and tuberculosis in regions where no vaccine ...
SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Detecting Drug-Induced Hypoventilation and Verbally Prompting for Patient Self-Rescue
SBC: Axon Medical Inc Topic: 600PROJECT SUMMARY ABSTRACT This Phase SBIR proposal focuses on increasing ventilation safety for patients as they recover from surgery in the hospital while also reducing the work burden for clinicians The underlying cause in of every unexpected hospital deaths is hypoventilation a condition in which patients do not breathe enough After surgery many patients receive medication to control p ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Memory Care Partner
SBC: Proactive Memory Services Topic: NIADESCRIPTION provided by applicant THE MEMORY CARE NAVIGATOR A PROACTIVE GUIDE Memory loss is an increasing problem as our population ages causing a tremendous personal and societal toll in disability and cost Alzheimerandapos s disease AD the most common cause of dementia is the illness elderly Americans most fear and the only major illness with an increasing mortality rate Despite subs ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
Automated Problem and Allergy Lists Enrichment Based on High Accuracy Information Extraction from the Electronic Health Record
SBC: Clinacuity, Inc Topic: NCIDESCRIPTION provided by applicant Medical errors are recognized as the cause of numerous deaths and even if some are difficult to avoid many are preventable Computerized physician order entry systems with decision support have been proposed to reduce this risk of medication errors but these systems rely on structured and coded information in the electronic health record EHR Unfortunately ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health -
In-Situ Gelling Protein Polymer Intravascular Embolic Agent for Hepatic Carcinoma
SBC: THERATARGET, INC. Topic: 102SUMMARY This STTR Phase II proposal addresses the significant need for improved treatment options for patients with liver cancerthe fifth highest incidence of cancer in the worldBecause of the lack of symptomshepatocellular carcinomaHCCis detected at advanced stages inof casesfor which theyear survival rate isand atyears it isThe only curative option for advanced HCC is surgical liver resection an ...
STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health